glp 1 agonist lilly The GLP-1 market is projected to exceed 100B USD by 2030 Lilly launches GLP-1 pill, kicking
Description
Fulcher G, Matthews DR, Perkovic V, de Zeeuw D, Mahaffey KW, Mathieu C, et al
One study demonstrated that less than a third individuals achieved greater than 5% weight loss during the three-year study period and only 25% of these individuals were able to maintain greater than 5% weight loss
These help you feel full and keep blood sugar stable
Komatsu R, Matsuyama T, Namba M, et al
Out of all patients with an overweight or obesity diagnosis who were prescribed a GLP-1 drug, the percentage of patients who had behavioral health services related to their condition declined from 2019 to 2024
Called reta by the longevity and bodybuilding communities online, retatrutide has shown pretty astounding efficacy at weight loss in clinical trials
